Showing results (1651-1660 of 2,288) with videos related to
Sort By:
Pageof 229
HIV Medicine|November 3, 2025
Quality improvement report: Investigating barriers in HIV testing oncology patients to optimize HIV testing practiceKatharine E A Darling, José Damas, Ana Leni Frei, et al.HIV Medicine|October 7, 2025
Antiretroviral treatment in people living with HIV with late diagnosis initiating ART with DTG/3TC or BIC/TAF/FTC: A real-world cohort analysisGundolf Schuettfort, Jan Borch, Alfonso Cabello, et al.HIV Medicine|October 6, 2025
Blood pressure and metabolic outcomes after efavirenz- or dolutegravir-based therapy started in acute HIV infectionPhillip Chan, Sarah Moreland, Carlo Sacdalan, et al.HIV Medicine|October 21, 2025
Clinical outcomes of long-acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real-world data from the Spanish RELATIVITY cohortJesús Troya, María Luisa Montes, María José Galindo, et al.HIV Medicine|September 12, 2025
Evaluating birth outcomes following oral rilpivirine use in pregnancy in the United States: Findings from the antiretroviral pregnancy registryWilliam R Short, Corinne Willame, Henry Nguyen, et al.HIV Medicine|September 8, 2025
Molecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment-naïve individuals with HIV-1 in TürkiyeAdem Özdemir, Tülin Demir, Ceylan Polat, et al.HIV Medicine|February 11, 2026
Perinatal and early infant outcomes after first-versus second-generation integrase strand transfer inhibitor use in pregnancyRosa Balleny, Jeffrey Man Hay Wong, Terry Lee, et al.HIV Medicine|February 11, 2026
Calibration and discrimination ability of the Dat'AIDS score in people living with HIV aged 70 years and older from the Dat'AIDS cohortAbeo Mousse, Clotilde Allavena, Amandine Gagneux-Brunon, et al.HIV Medicine|November 15, 2022
High-level compliance to opt-out HIV testing in the emergency department (ED) of a large teaching hospital using the biochemistry sample as the sample type for HIV screeningRebecca Marchant, Anne Patterson, Bojana Dragovic, et al.HIV Medicine|February 1, 2026
Virological outcomes with Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in people previously treated with darunavir-based antiretroviral therapyRhianna Sheridan, Yasmin Osei-Kuffour Ekert, Lucy Campbell, et al.Pageof 229